2016

A study of proteomics pattern of tissue subtypes of lung adenocarcinoma in the King Chulalongkorn Memorial Hospital

Benyapatch Eiamthanasinchai, M.D., Thammakorn Saethang, M.D., Trairak Pisitkun, M.D., Poonchavist Chantranuwatana, M.D. and Virote Sriuranpong, M.D.

Serum CYFRA 21-1 and CEA level as predicting markers for non-small cell lung cancer stages III and IV

Punlert Tanyakul, M.D., Apichat Tantraworasin, M.D. and Busyamas Chewaskulyong, M.D.

Outcome and Characteristics of Lung Cancer Patients That Non-Received Treatment in Maharaj Nakorn Chiangmai Hospital

Anantaporn Pooprasert, M.D. and Chaiyut Charoentum, M.D.

Programmed death ligand-1 (PD-L1) expression in Resectable Cholangiocarcinoma Patients in Srinakarind Hospital

Piangpen Jongpairat, M.D.

Evaluation of clinical predictive model for chemotherapy induced febrile neutropenia in breast cancer at Rajavithi Hospital

Chaichana Chantharakhit, M.D., Jedzada Maneechavakajorn, M.D.

Survival outcome of advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors in Rajavithi Hospital

Pajeepatoo Wannarat, M.D., Songwit Payapwattanawong, M.D., Sudsawat Laohavinij, Ph.D. M.D. and Piyawan Tainchaianan, M.D.

Explanation Models Using Pathological Data for Clinical Treatment Outcome of Early-Stage Breast Cancer Patients With Hormonal Receptor (HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative

Sukhanit Promrub, M.D., Siriwimon Saichaemchan, M.D., Khunthong Pechatanan, M.D., Kasan Seetalarom, M.D. and Naiyarat Prasoongsook, M.D.

Incidence Throbocytopenia in Colon Stage III Who Received Oxaliplatin Base Regimen

Praewphan Ruangekawit, M.D., Nuttapong Ngamphaiboon, M.D. and Ekaphop Sirachainan, M.D.

Comparison of C-telopeptide of Original Zoledronate and Generic Zoledronate in Cancer Patients with Bone Metastasis

Nathamon Panomuppakarn, M.D. and Thitiya Dejthevaporn, M.D.

Prevalence, Pattern and Impact of PD-L1 Expression and HPV-status in Head and Neck Squamous Cell Carcinoma

Theeranut Chureemas, M.D., Noppadol Larbcharoensub, M.D., Jitlada Juengsamarn, M.D., Thanarat Layangkool, M.D., Chutima Jiarpinitnun, M.D., Phichai Chansriwong, M.D., Narumol Trachu, Poompis Pattaranutaporn, M.D. and Nattapong Ngamphaiboon, M.D.

The Impact of Age In Treatment Outcome of Squamous Cell Carcinoma In Head and Neck Cacncer Patient

Jitlada Juengsamarn, M.D., Nuttapong Ngamphaiboon, M.D., Chuleeporn Jiarpinitnun, M.D., Poompis Pattaranutaporn, M.D. and Phichai Chansriwong, M.D.

Role of BIM Deletion Polymorphism and BIM Expression As The Predictive Biomarkers To Maximize The Benefit of EGFR TKI Treatment In EGFR Positive NSCLC

Chanchai Charonpongsuntorn, M.D., Pimpin Incharoen, M.D., Narumol Trachu, Kaettipong Kampreasart, M.D., Dittapol Muntham, Sakditad Saowapa, M.D., Ekaphop Sirichainan, M.D. and Thanyanan Reungwetwattana, M.D.

Overall Survival In Patients With Non-metastatic Muscle-invasive Bladder Cancer (Stage II-IV) Receiving Neoadjuvant or Adjuvant Chemotherapy In Siriraj Hospital

Chayanee Samdaengpan, M.D., ChalairatSuk-ouichai, M.D. and Sirisopa Techawattanawanna, M.D.

Male breast cancer: Treatment outcome at Siriraj hospital: 10-year experience

Patraporn Maneenawachai, M.D. and Vichien Srimuninnimit, M.D.

Efficacy of Ginger for Chemotherapy-induced Nausea and Vomiting Prophylaxis In Breast Cancer Patients Receiving Adriamycin – Cyclophosphamide Regimen: A Randomized Double-blind Placebo-control Crossover Study

Lucksamon Thamlikitkul, M.D., Vichien Srimuninnimit, M.D., Charuwan Akewanlop, M.D., Suthinee Ithimakin, M.D., Sirisopa Techawathanawanna, M.D., Krittiya Korphaisarn, M.D., Jomjit Chantharasamee, M.D., Pongwut Danchaivijitr, M.D., Nopadol Soparattanapaisarn, M.D.

Cost Effective Analysis of EGFR Mutation Testing Before Initiation of Second Line Therapy In Advanced Adenocarcinoma of Lung

Tanawade Sirithanadepan, M.D.

The Accuracy of Carboplatin Area Under the Plasma Concentration Time Curve (AUC) Estimated by Calvert Formula Using Cockcroft-Gault formula and Thai eGFR in Thai Cancer Patients

Kokiet Kangwantas, M.D., Panneeb Chinjarernpan, Viroteb Sriuranpong, Napab Parinyanitikul, Piyadab Sitthideatphaiboon, Nattayab Poovorawan, and Suebpong Tanasanvimon, M.D.

Incidence of Infusion Hypersensitivity Reaction After Withholding Dexamethasone Premedication in Early Breast Cancer Patients Not Experiencing Two Previous Cycles of Infusion Hypersensitivity Reaction for Weekly Paclitaxel Chemotherapy

Walailuk Tanpipattanakul, M.D., Nattaya Poovorawan, M.D., Thanapoom Rattananupong, M.D., Poranee Laoitthi, M.D., Piyada Sithidetphaiboon, M.D., Suebpong Thanasanvimon, M.D., Virote Sriuranpong, M.D. and Napa Parinyanitikul, M.D.